• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Promoting evidence-based health care in Africa
Charles Shey Wiysonge, Director ofCochane  South Africa, gave an interview to the World Health Organization Bulletin. Here is a re-post , with premission, from their  recent publication.Charles Shey Wiysonge is devoted to encouraging better use of scientific evidence for health policies and programmes in African countries. He is the director of the South African Cochrane Centre, a unit of the South African Medical Research Council, and a professor of epidemiology and biostatistics at the department of Global Health in the Faculty of Medicine and Health Sciences at Stellenbosch University in South Africa. He was Chief Res...
Source: Cochrane News and Events - August 17, 2017 Category: Information Technology Authors: Muriah Umoquit Source Type: news

CNS Summit 2017 Abstracts of Poster Presentations
Conclusion: This novel technology discriminates and quantifies subtle differences in behavior and neurological impairments in subjects afflicted with neurological injury/disease. KINARM assessments can be incorporated into multi-center trials (e.g., monitoring stroke motor recovery: NCT02928393). Further studies will determine if KINARM Labs can demonstrate a clinical effect with fewer subjects over a shorter trial period. Disclosures/funding: Dr. Stephen Scott is the inventor of KINARM and CSO of BKIN Technologies.   Multiplexed mass spectrometry assay identifies neurodegeneration biomarkers in CSF Presenter: Chelsky...
Source: Innovations in Clinical Neuroscience - November 1, 2017 Category: Neuroscience Authors: ICNS Online Editor Tags: Assessment Tools biomarkers Cognition Current Issue Drug Development General Genetics Medical Issues Neurology Patient Assessment Psychopharmacology Scales Special Issues Supplements Trial Methodology clinical trials CNS Su Source Type: research

Preparations for the upcoming pilgrimage: heat exhaustion and respiratory diseases are the priority
Over 2 million Muslim pilgrims are expected to participate in this year’s hajj that begins next week in Saudi Arabia’s holy city of Mecca. In preparation, the Saudi Ministry of Health with support from World Health Organization (WHO) has put in place measures to prevent and rapidly address any health issues that could arise during the hajj, including the Middle East respiratory syndrome coronavirus (MERS-CoV) and other respiratory diseases. In addition, WHO has contributed to the training of more than 25 health cadres from the cities of Jeddah, Mecca and Madinah on rapid response to health emergencies. The training f...
Source: WHO EMRO News - September 6, 2016 Category: Middle East Health Source Type: news

Preparations for the upcoming pilgrimage: heat exhaustion and respiratory diseases are a priority
Over 2 million Muslim pilgrims are expected to participate in this year’s hajj that begins next week in Saudi Arabia’s holy city of Mecca. In preparation, the Saudi Ministry of Health with support from World Health Organization (WHO) has put in place measures to prevent and rapidly address any health issues that could arise during the hajj, including the Middle East respiratory syndrome coronavirus (MERS-CoV) and other respiratory diseases. In addition, WHO has contributed to the training of more than 25 health cadres from the cities of Jeddah, Mecca and Madinah on rapid response to health emergencies. The training f...
Source: WHO EMRO News - September 6, 2016 Category: Middle East Health Source Type: news